INS and familial pancreatic carcinoma: The mechanisms leading to this positive association was uncertain, as pancreatic cancer cells were previously shown to respond similarly to insulin glargine and human insulin, and survival in insulin glargine-treated patients after treatment for pancreatic cancer was similar to those on human insulin [18].